These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 24905440)

  • 1. Prostate progenitor cells proliferate in response to castration.
    Shi X; Gipp J; Dries M; Bushman W
    Stem Cell Res; 2014 Jul; 13(1):154-63. PubMed ID: 24905440
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A rare castration-resistant progenitor cell population is highly enriched in Pten-null prostate tumours.
    Sackmann Sala L; Boutillon F; Menara G; De Goyon-Pélard A; Leprévost M; Codzamanian J; Lister N; Pencik J; Clark A; Cagnard N; Bole-Feysot C; Moriggl R; Risbridger GP; Taylor RA; Kenner L; Guidotti JE; Goffin V
    J Pathol; 2017 Sep; 243(1):51-64. PubMed ID: 28603917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The influence of prostatic anatomy and neurotrophins on basal prostate epithelial progenitor cells.
    Höfner T; Klein C; Eisen C; Rigo-Watermeier T; Haferkamp A; Trumpp A; Sprick MR
    Prostate; 2016 Jan; 76(1):114-21. PubMed ID: 26444457
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Label retention and stem cell marker expression in the developing and adult prostate identifies basal and luminal epithelial stem cell subpopulations.
    Ceder JA; Aalders TW; Schalken JA
    Stem Cell Res Ther; 2017 Apr; 8(1):95. PubMed ID: 28446230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early human prostate adenocarcinomas harbor androgen-independent cancer cells.
    Fiñones RR; Yeargin J; Lee M; Kaur AP; Cheng C; Sun P; Wu C; Nguyen C; Wang-Rodriguez J; Meyer AN; Baird SM; Donoghue DJ; Haas M
    PLoS One; 2013; 8(9):e74438. PubMed ID: 24086346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urethral luminal epithelia are castration-insensitive cells of the proximal prostate.
    Joseph DB; Henry GH; Malewska A; Iqbal NS; Ruetten HM; Turco AE; Abler LL; Sandhu SK; Cadena MT; Malladi VS; Reese JC; Mauck RJ; Gahan JC; Hutchinson RC; Roehrborn CG; Baker LA; Vezina CM; Strand DW
    Prostate; 2020 Aug; 80(11):872-884. PubMed ID: 32497356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enrichment of putative prostate cancer stem cells after androgen deprivation: upregulation of pluripotency transactivators concurs with resistance to androgen deprivation in LNCaP cell lines.
    Seiler D; Zheng J; Liu G; Wang S; Yamashiro J; Reiter RE; Huang J; Zeng G
    Prostate; 2013 Sep; 73(13):1378-90. PubMed ID: 23728788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sox2 is an androgen receptor-repressed gene that promotes castration-resistant prostate cancer.
    Kregel S; Kiriluk KJ; Rosen AM; Cai Y; Reyes EE; Otto KB; Tom W; Paner GP; Szmulewitz RZ; Vander Griend DJ
    PLoS One; 2013; 8(1):e53701. PubMed ID: 23326489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New therapeutic approach to suppress castration-resistant prostate cancer using ASC-J9 via targeting androgen receptor in selective prostate cells.
    Lai KP; Huang CK; Chang YJ; Chung CY; Yamashita S; Li L; Lee SO; Yeh S; Chang C
    Am J Pathol; 2013 Feb; 182(2):460-73. PubMed ID: 23219429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methylselenocysteine preventing castration-resistant progression of prostate cancer.
    Liu Y; Liu X; Guo Y; Liang Z; Tian Y; Lu L; Zhao X; Sun Y; Zhao X; Zhang H; Dong Y
    Prostate; 2015 Jun; 75(9):1001-8. PubMed ID: 25754033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stem-like cells with luminal progenitor phenotype survive castration in human prostate cancer.
    Germann M; Wetterwald A; Guzmán-Ramirez N; van der Pluijm G; Culig Z; Cecchini MG; Williams ED; Thalmann GN
    Stem Cells; 2012 Jun; 30(6):1076-86. PubMed ID: 22438320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Androgen-insensitive prostate cancer cells transiently respond to castration treatment when growing in an androgen-dependent prostate environment.
    Halin S; Hammarsten P; Wikström P; Bergh A
    Prostate; 2007 Mar; 67(4):370-7. PubMed ID: 17192959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estrogen receptor β activation impairs prostatic regeneration by inducing apoptosis in murine and human stem/progenitor enriched cell populations.
    Hussain S; Lawrence MG; Taylor RA; Lo CY; ; Frydenberg M; Ellem SJ; Furic L; Risbridger GP
    PLoS One; 2012; 7(7):e40732. PubMed ID: 22808245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histone 2B-GFP Label-Retaining Prostate Luminal Cells Possess Progenitor Cell Properties and Are Intrinsically Resistant to Castration.
    Zhang D; Jeter C; Gong S; Tracz A; Lu Y; Shen J; Tang DG
    Stem Cell Reports; 2018 Jan; 10(1):228-242. PubMed ID: 29276153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The PSA(-/lo) prostate cancer cell population harbors self-renewing long-term tumor-propagating cells that resist castration.
    Qin J; Liu X; Laffin B; Chen X; Choy G; Jeter CR; Calhoun-Davis T; Li H; Palapattu GS; Pang S; Lin K; Huang J; Ivanov I; Li W; Suraneni MV; Tang DG
    Cell Stem Cell; 2012 May; 10(5):556-69. PubMed ID: 22560078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Testosterone boosts for treatment of castration resistant prostate cancer: an experimental implementation of intermittent androgen deprivation.
    Thelen P; Heinrich E; Bremmer F; Trojan L; Strauss A
    Prostate; 2013 Nov; 73(15):1699-709. PubMed ID: 23868789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dutasteride and enzalutamide synergistically suppress prostate tumor cell proliferation.
    Hamid AR; Verhaegh GW; Smit FP; van Rijt-van de Westerlo C; Armandari I; Brandt A; Sweep FC; Sedelaar JP; Schalken JA
    J Urol; 2015 Mar; 193(3):1023-9. PubMed ID: 25242390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prostatic environment suppresses growth of androgen-independent prostate cancer xenografts: an effect influenced by testosterone.
    Jennbacken K; Gustavsson H; Tesan T; Horn M; Vallbo C; Welén K; Damber JE
    Prostate; 2009 Aug; 69(11):1164-75. PubMed ID: 19399749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TACC2 is an androgen-responsive cell cycle regulator promoting androgen-mediated and castration-resistant growth of prostate cancer.
    Takayama K; Horie-Inoue K; Suzuki T; Urano T; Ikeda K; Fujimura T; Takahashi S; Homma Y; Ouchi Y; Inoue S
    Mol Endocrinol; 2012 May; 26(5):748-61. PubMed ID: 22456197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generation of a prostate from a single adult stem cell.
    Leong KG; Wang BE; Johnson L; Gao WQ
    Nature; 2008 Dec; 456(7223):804-8. PubMed ID: 18946470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.